found that the risk of developing RA was increased among women who had given birth to a child with an allele encoding the shared epitope (adjusted for the mother's status as a carrier of RA-risk alleles; OR 3.0, 95% CI 2.0-4.6).
Bidirectional exchange of cells between the mother and fetus during pregnancy creates a long-term legacy. A mother's cells persist in her progeny into adult life, and cells of fetal origin are present in women for many years following a pregnancy, potentially persisting for a lifetime (FIG. 1) . These small populations of naturally occurring immigrant cells carry a complement representing HLA-DRB1*04:01, conferred a risk of developing RA in both risk-allele carrier and non-carrier mothers (P = 0.01 and P = 0.001, respectively).
These observations bring to mind an intriguing aspect of RA immunogenetics, namely that there is a hierarchy of RA-risk 5 depending on the HLA genotype of an individual, and that the three different shared epitope sequences are not equivalent. At the top of the hierarchy is HLA-DRB1*04:01, which confers risk irrespective of the second haplotype, whereas the other shared epitope sequences are most potent in specific combinations, a phenomenon referred to as compound heterozygosity. Consideration of this hierarchy provides a potentially analogous explanation for the observations of Cruz et al. Briefly, carrying a child with the strongest shared epitope sequence (QKRAA, HLA-DRB1*04:01 with a lysine at position 71) will be sufficient to confer risk, but carrying a child with any of the other shared epitope sequences will only be sufficient to confer risk if they are present in the context of another shared epitope sequence. Lending support to this interpretation, Rak et al. 3 observed a higher occurrence of HLA-DRB1*04-positive microchimerism in HLA-DRB1*01-positive patients with RA than HLA-DRB1*01-positive microchimerism in HLA-DRB1*04-positive patients with RA. In this study 3 , it was assumed that HLA-DRB1*04 and HLA-DRB1*01 microchimerism primarily consisted of shared epitope-encoding alleles. In a subsequent study, QKRAA and QRRAA microchimerism was directly demonstrated 4 . Neither study 3, 4 distinguished the source of shared epitope-positive microchimerism.
Non-inherited maternal HLA alleles can also have long-lasting effects on her progeny. The sequence DERAA, encoded at the same amino acid positions as the shared epitope but by other HLA-DRB1 alleles, is considered to be RA-protective in most studies. As discussed by Cruz et al. 1 , a previous study in patients with RA showed a deficit of non-inherited maternal alleles encoding DERAA compared with non-inherited paternal alleles. In light of this evidence, the finding of an increased risk of RA among women with a child who had a DERAAencoding allele was unexpected 1 . Although the explanation for this finding is unknown, one consideration is that the effect of maternal cells acquired during fetal life (when the immune of genes that differ from the individual who acquires them, a phenomenon known as microchimerism, and can confer benefits or risks to that individual's long-term health 2 . This potential for a child's genetic makeup to influence maternal health later in life can be considered akin to 'reverse inheritance' .
Two previous studies provided evidence that women with RA who are negative for the shared epitope more frequently harbour shared epitope-positive microchimerism than healthy women 3, 4 . When Cruz et al. 1 stratified patients according to their shared epitope status, shared epitope-positive mothers with RA were more likely to have had a shared epitope-positive child than matched healthy women. Surprisingly, the corresponding results were not statistically significant for shared epitope-negative mothers, although the number of shared epitope-negative mothers among cases was low (31 shared epitopenegative cases among the 170 total cases). Stratified analysis did, however, indicate that having a child or children who carry alleles encoding lysine at position 71, essentially
R H E U M ATO I D A RT H R I T I S
Forward and reverse inheritancethe yin and the yang
J. Lee Nelson and Nathalie C. Lambert
The theory of Mendelian inheritance states that half our genes are maternal and half are paternal. This view is incomplete, as maternal-fetal exchange creates a legacy of non-native cells within an individual that can affect their health for better or worse, including contributing to their risk of developing autoimmune disease. Bidirectional exchange of cells between the mother and fetus during pregnancy creates a long-term legacy system is developing) can be expected to differ from that of fetal cells acquired by an adult woman (when the immune system is mature). Functional studies have not yet addressed this subject, although other kinds of unexpected outcomes in the maternal-fetal relationship have been described. For example, children born to mothers with type I diabetes mellitus were less likely to develop the disease when islet-specific autoantibodies were present in cord blood than when they were absent, contrary to expectations 6 . Also, variable results were reported in studies that evaluated RA risk according to whether the non-inherited maternal HLA allele encoded a shared epitope sequence 7 . What is missing is a study that evaluates the effect of both the non-inherited maternal HLA allele and the paternally transmitted HLA allele of children born before disease onset in women with RA.
Another variable that could affect results is gravidity without parity. The majority of studies have found an overall decrease in RA risk in parous women, as compared with nulliparous women 8, 9 . Both spontaneous and induced abortion can also result in microchimerism 2 ; however, gravidity without parity seems to confer no protection against RA 8 . Other sources of microchimerism include a recognized or unrecognized twin and, potentially, previous microchimerism from an older sibling or maternal miscarriage, passed along with maternal cells to a child born later in the mother's life 2 (FIG. 1) . Together, these microchimeric cells might be likened to a patchwork within the individual, creating increased genetic diversity in women and having variable effects depending on the source of the cells and the timing of acquisition, among other factors.
Naturally acquired microchimerism can be tissue-specific or haematopoietic, and harbouring multiple microchimeric 'grafts' across generations in women is of special interest, as highlighted by experimental studies 10 . Much can be learned from elucidating the long-term consequences of forward and reverse inheritance; in terms of both the benefits and the risks that can be accrued from our immigrant cell populations, acquired as a natural form of 'mini-gene transfer' .
